The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Two South African harm reduction sites are among the many casualties. “I owe my HIV-negative status to their efforts,” says a ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

These medications are life and death for someone coming out of custody and in that state,” said Mary Taylor, a clinical ...

President Trump’s pause on aid, and the gutting of the primary aid agency, could jeopardize the health of more than 20 ...

"It's a huge deal," Haley Chatelaine, PhD, a postdoctoral fellow studying basic cellular functions at the NIH who helps ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Novo’s newest GLP-1, CagriSema, is the first big test of Novo Nordisk’s future as the leader in the obesity treatment market.

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...